1.71
전일 마감가:
$1.72
열려 있는:
$1.73
하루 거래량:
185.49K
Relative Volume:
1.73
시가총액:
$21.37M
수익:
$10.16M
순이익/손실:
$-47.57M
주가수익비율:
-0.2075
EPS:
-8.24
순현금흐름:
$-42.73M
1주 성능:
+2.40%
1개월 성능:
+6.87%
6개월 성능:
-42.62%
1년 성능:
-67.12%
Curis Inc Stock (CRIS) Company Profile
명칭
Curis Inc
전화
617-503-6500
주소
128 SPRING STREET, LEXINGTON, MA
CRIS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CRIS
Curis Inc
|
1.71 | 20.50M | 10.16M | -47.57M | -42.73M | -8.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-19 | 재개 | H.C. Wainwright | Buy |
2023-11-17 | 개시 | Truist | Buy |
2022-04-04 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2021-10-13 | 개시 | Raymond James | Outperform |
2021-03-25 | 개시 | B. Riley Securities | Buy |
2020-07-29 | 개시 | Laidlaw | Buy |
2020-07-17 | 개시 | Cantor Fitzgerald | Overweight |
2017-10-24 | 개시 | Guggenheim | Buy |
2016-03-02 | 개시 | Sun Trust Rbsn Humphrey | Buy |
2015-11-09 | 재확인 | ROTH Capital | Buy |
2015-08-11 | 개시 | FBR Capital | Outperform |
2015-01-22 | 재확인 | Oppenheimer | Outperform |
2015-01-21 | 재확인 | ROTH Capital | Buy |
2014-05-09 | 재확인 | Oppenheimer | Outperform |
2013-10-02 | 개시 | Robert W. Baird | Outperform |
2013-09-30 | 개시 | Chardan Capital Markets | Buy |
2012-11-14 | 개시 | Stifel Nicolaus | Hold |
2012-01-31 | 재확인 | Brean Murray | Buy |
2012-01-31 | 재확인 | Summer Street Research | Buy |
2011-12-09 | 개시 | Oppenheimer | Outperform |
2011-10-06 | 개시 | Summer Street Research | Buy |
2011-09-22 | 개시 | MLV Capital | Buy |
2011-03-21 | 재확인 | Brean Murray | Buy |
2010-02-26 | 재확인 | Roth Capital | Buy |
2010-01-07 | 개시 | Roth Capital | Buy |
모두보기
Curis Inc 주식(CRIS)의 최신 뉴스
What moving averages say about Curis Inc.July 2025 Technicals & Verified Swing Trading Watchlists - Newser
Regression analysis insights on Curis Inc. performancePortfolio Return Summary & Expert Approved Momentum Trade Ideas - Newser
Is Curis Inc. showing signs of accumulationEarnings Miss & Verified Trade Idea Suggestions - Newser
Market reaction to Curis Inc.’s recent news2025 Top Gainers & Free Weekly Watchlist of Top Performers - Newser
How to track smart money flows in Curis Inc.2025 Big Picture & Fast Gain Swing Alerts - Newser
How sentiment analysis helps forecast Curis Inc.July 2025 Snapshot & Free High Accuracy Swing Entry Alerts - Newser
Is Curis Inc. forming a reversal pattern2025 Market Outlook & High Conviction Buy Zone Alerts - Newser
Can volume confirm reversal in Curis Inc.July 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Does Curis Inc. fit your quant trading modelJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - Newser
Signal strength of Curis Inc. stock in tech scannersPortfolio Update Report & Growth Oriented Trade Recommendations - Newser
What earnings revisions data tells us about Curis Inc.July 2025 Closing Moves & Advanced Swing Trade Entry Alerts - Newser
Is it too late to sell Curis Inc.Sell Signal & Free Safe Entry Trade Signal Reports - Newser
What’s the beta of Curis Inc. stockPortfolio Gains Summary & Free AI Powered Buy and Sell Recommendations - khodrobank.com
Will Curis Inc. stock benefit from interest rate changesQuarterly Portfolio Summary & Daily Entry Point Alerts - Newser
Can machine learning forecast Curis Inc. recovery2025 Volume Leaders & Expert Curated Trade Ideas - Newser
What’s the outlook for Curis Inc.’s sectorRecession Risk & Weekly High Return Stock Forecasts - khodrobank.com
Curis to Present at Upcoming Healthcare Conferences in September - The Malaysian Reserve
Curis CEO to Participate in Cantor and H.C. Wainwright Conferences - AInvest
Biotech Innovator Curis to Showcase Emavusertib IRAK4 Inhibitor at Major Healthcare Conferences - Stock Titan
What is the PEG ratio of Curis Inc.Trade Risk Report & Safe Capital Growth Stock Tips - khodrobank.com
EPS Watch: Can Curis Inc. continue delivering strong returnsJuly 2025 News Drivers & Weekly Momentum Picks - khodrobank.com
What institutional flow reveals about Curis Inc.July 2025 PostEarnings & High Return Trade Opportunity Guides - Newser
Should you hold or exit Curis Inc. nowTrade Ideas & Weekly High Momentum Picks - Newser
Published on: 2025-09-01 03:26:10 - Newser
Automated trading signals detected on Curis Inc.2025 Retail Activity & Low Drawdown Trading Techniques - Newser
Is Curis Inc. a speculative investment2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - khodrobank.com
Can volume confirm reversal in Curis IncPortfolio Growth Summary & High Accuracy Trade Alerts - Newser
How sentiment analysis helps forecast Curis IncJuly 2025 Rallies & Verified Entry Point Detection - Newser
Is Curis Inc. stock ready for a breakoutJuly 2025 Drop Watch & Safe Entry Point Identification - Newser
Backtesting results for Curis Inc. trading strategies2025 EndofYear Setup & Consistent Income Trade Recommendations - Newser
Is Curis Inc. Starting a New Uptrend getLinesFromResByArray error: size == 0 - thegnnews.com
Short interest data insights for Curis Inc.Long Setup & Risk Controlled Daily Trade Plans - Newser
Relative strength of Curis Inc. in sector analysis2025 Performance Recap & Entry Point Strategy Guides - Newser
Curis Inc (CRIS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):